FTRE vs IDYA Stock Comparison

FTRE currently leads IDYA in this stock comparison, with AIQ scores of 75 vs 54. The clearest difference is value, while IDYA has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 21 points
FTRE
Healthcare
vs
IDYA
Healthcare
FTRE
Fortrea Holdings Inc.
Leads
Price
$20.20
Day move
+0.7%
AIQ Score
75/100
Best edge
Value
Sector
Healthcare
IDYA
IDEAYA Biosciences, Inc.
Price
$31.83
Day move
+1.08%
AIQ Score
54/100
Best edge
Risk Resilience
Sector
Healthcare

What is the main difference between FTRE and IDYA?

FTRE leads the current stock comparison as Fortrea Holdings Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Fortrea Holdings Inc. vs IDEAYA Biosciences, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 8/10

FTRE leads

FTRE leads by 21 AIQ points, primarily on Value and Momentum, and the lead has widened from 14 points over 30 sessions. Wall Street currently favors IDYA on target upside.

Stable: 3 of 6 evidence groups support FTRE, its lead is widening, and its signal state is cleanly positive.

Evidence agreement: 3 of 6Comparison trend: Strengthening
FTRE

Fortrea Holdings Inc.

Leads
AIQ Score
75/100
AIQ Edge Score
9/10
IDYA

IDEAYA Biosciences, Inc.

AIQ Score
54/100
AIQ Edge Score
5/10

The Algovestiq AIQ Score currently favors FTRE over IDYA, 75 versus 54 as of Nov 15, 2026. FTRE's advantage is driven primarily by stronger value and momentum, while IDYA holds the stronger risk resilience profile. FTRE also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors IDYA. 3 of 6 covered evidence groups favor FTRE today, and the comparison is rated Stable on stability: only 3 of 6 covered evidence groups agree. FTRE lead: Strengthening — the AIQ differential moved from 14 to 21 points over 30 sessions.

Compare Fortrea Holdings Inc. and IDEAYA Biosciences, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

FTRE
-45.2%
IDYA
+39.2%

Price return comparison

Growth of $10,000, price only

FTRE $5,483 · IDYA $13,918

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare FTRE and IDYA against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

FTRE advantage
0
IDYA advantage
  • Value93 vs 39
    FTRE +54
  • Momentum88 vs 63
    FTRE +25
  • Risk Resilience41 vs 61
    IDYA +20
  • Quality65 vs 51
    FTRE +14

3 of 6 evidence groups favor FTRE. FTRE’s edge is concentrated in value and momentum; IDYA keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

FTRE+1 AIQ

Largest factor move: Quality +1

New signals

  • ADX Trend Weakening — neutral, trend, medium horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-10.2%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon
IDYA0 AIQ

Largest factor move: Value +2, not enough on its own to move the overall score.

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-3.1%)

FTRE's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — FTRE and IDYA both carry a full feed there.

The central trade-off

FTRE (Fortrea Holdings Inc.): the stronger current systematic profile, led by value and momentum.

IDYA (IDEAYA Biosciences, Inc.): the counter-case, on risk resilience, fundamentals, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

FTRE

FTRE on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

FTRE

FTRE on combined revenue and EPS growth.

Value

FTRE

FTRE on the peer-relative Value factor, by 54 points.

Momentum

FTRE

FTRE on the Momentum factor, by 25 points.

Lower downside

IDYA

IDYA on Risk Resilience, by 20 points.

Analyst upside

IDYA

IDYA on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors FTRE, analyst targets favor IDYA. That disagreement is the most useful thing on this page.

MeasureFTREIDYANote
Implied upside to target+22.5%+53.2%IDYA has more room
Target dispersion+30.3%+36.9%Lower is tighter analyst agreement
ConsensusHoldBuyContext, not a primary driver
Analysts covering1516Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor FTRE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreFTRE75 vs 54
FundamentalsIDYAon balancerevenue growth 2% vs 15.6%; gross margin 18.5% vs 100%; operating margin 1.6% vs -12.7% — IDYA takes 2 of 3 decided legs, not all of them
ValuationFTREValue 93 vs 39
TechnicalsFTREPrice vs 50-day -2.7% vs -10.3%; vs 200-day 27% vs -6%
Risk ResilienceIDYARisk Resilience 41 vs 61
Analyst expectationsIDYATarget upside 22.5% vs 53.2%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of FTRE and IDYA and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 21 points. (supports the conclusion holding)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader's signal state is cleanly positive. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on FTRE.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

FTRE lead: Strengthening — the AIQ differential moved from 14 to 21 points over 30 sessions.

May 27FTRE leads above the line · IDYA leads belowNov 13
Today
FTRE +21
75 vs 54
7 sessions ago
FTRE +20
74 vs 54
30 sessions ago
FTRE +14
77 vs 63
90 sessions ago
FTRE +10
75 vs 65

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

FTRE

4 bullish / 0 bearish / 2 neutral

Only FTRE

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Stochastic Oversold Bounce — bullish, momentum, short horizon
IDYA

4 bullish / 0 bearish / 2 neutral

Only IDYA

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

Both carry 4 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, OBV Bullish Divergence, RSI Bullish Divergence.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

FTREConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +0.7%, AIQ +1 points).

IDYANo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.08%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1IDYA closes the Value gap — currently 54 points behind, the largest single contributor to FTRE's edge.
  2. 2IDYA generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover or EMA Ribbon Expansion Bullish.
  3. 3FTRE's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

IDYA leads on balance
MetricFTREIDYA
Revenue growth (YoY)2%15.6%
EPS growth (YoY)104.5%0%
Gross margin18.5%100%
Operating margin1.6%-12.7%
Return on equity (TTM)0.1%-11.5%
Debt to equity2.10.03

Performance

FTRE leads 4 of 6 windows
MetricFTREIDYA
1 week (5 sessions)-8%1.9%
1 month (20 sessions)-10.2%-3.1%
3 months (63 sessions)11.6%-12.9%
6 months (126 sessions)47.9%12.8%
Year to date17.1%-7.9%
1 year (252 sessions)78.1%-0.4%

Technicals

FTRE has the stronger structure
MetricFTREIDYA
RSI (14)43.542.4
ADX (14)24.425.8
Price vs 50-day-2.7%-10.3%
Price vs 200-day27%-6%
Volatility (1M, annualized)73.4%48.2%

Risk

IDYA is the more resilient
MetricFTREIDYA
Beta1.620.94
Sharpe ratio1.290.14
Sortino ratio2.020.2
Max drawdown-51.8%-27.8%
Current drawdown-21.9%-25.1%
Annualized volatility67.3%44.9%
Value at risk (95%)-6%-4.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, FTRE or IDYA?

On the Algovestiq AIQ Score, FTRE is the stronger of the two as of Nov 15, 2026, scoring 75 against IDYA's 54. The edge comes from value and momentum. IDYA is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is FTRE or IDYA the better buy right now?

FTRE carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 3 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor FTRE over IDYA?

The composite weights Quality, Value, Momentum and Risk Resilience. FTRE leads Value by 54 points; FTRE leads Momentum by 25 points; IDYA leads Risk Resilience by 20 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, FTRE or IDYA?

Analyst price targets imply +22.5% upside for FTRE and +53.2% for IDYA, so the Street currently favors IDYA. That points the opposite way to the AIQ Score, which favors FTRE. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, FTRE or IDYA?

FTRE is the better-valued of the two on the peer-relative Value factor. FTRE on the peer-relative Value factor, by 54 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, FTRE or IDYA?

FTRE on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, FTRE or IDYA?

FTRE on the Momentum factor, by 25 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, FTRE or IDYA?

IDYA is the more resilient of the two, so the other name carries the higher downside risk. IDYA on Risk Resilience, by 20 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is FTRE more profitable than IDYA?

The profitability evidence is mixed: gross margin 18.5% vs 100%; operating margin 1.6% vs -12.7%; ttm roe 0.1% vs -11.5%. Each name leads on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is FTRE's lead over IDYA getting stronger or weaker?

FTRE lead: Strengthening — the AIQ differential moved from 14 to 21 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the FTRE vs IDYA verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: IDYA closes the Value gap — currently 54 points behind, the largest single contributor to FTRE's edge; IDYA generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover or EMA Ribbon Expansion Bullish; FTRE's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about FTRE and IDYA?

FTRE: 4 bullish / 0 bearish / 2 neutral. IDYA: 4 bullish / 0 bearish / 2 neutral. The most decision-relevant rule on FTRE is Golden Cross Active (bullish, long horizon). On IDYA it is Golden Cross Active (bullish, long horizon).

Compare FTRE and IDYA with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.